Asia Pacific Androgenetic Alopecia Market Size, Share & Trends Analysis Report By Treatment (Pharmaceuticals, and Devices), By Gender (Male, and Female), By Sales Channel, By Country and Growth Forecast, 2023 - 2030

The Asia Pacific Androgenetic Alopecia Market would witness market growth of 9.0% CAGR during the forecast period (2023-2030).

The China market dominated the Asia Pacific Androgenetic Alopecia Market, By Country in 2022, and would continue to be a dominant market till 2030; thereby, achieving a market value of $364.8 Million by 2030. The Japan market is showcasing a CAGR of 8.3% during (2023 - 2030). Additionally, The India market would register a CAGR of 9.7% during (2023 - 2030).

With the availability of information online, consumers are more empowered to research and make informed decisions about their healthcare. The democratization of information enables individuals to explore various options, understand potential risks and benefits, and actively participate in discussions with healthcare providers. This sense of empowerment has led to a proactive approach in seeking and adopting androgenetic alopecia interventions. The adoption of surgical interventions, particularly hair transplantation techniques like Follicular Unit Transplantation (FUT) and Follicular Unit Extraction (FUE), is on the rise. These procedures involve the transplantation of healthy hair follicles from one part of the scalp to the balding areas, providing a permanent solution to androgenetic alopecia.

These are among the most widely adopted pharmaceutical products for androgenetic alopecia. Minoxidil, available as a topical solution, stimulates hair growth, while finasteride, an oral medication, inhibits the effects of the hormone dihydrotestosterone (DHT), a major contributor to hair loss in androgenetic alopecia. Low-level laser therapy (LLLT) devices, such as laser caps and helmets, are gaining adoption for their non-invasive approach to stimulating hair follicles and promoting hair growth. Platelet-rich plasma (PRP) injections involve using the patient’s plasma to stimulate hair follicles. This non-surgical option has seen increased adoption for its minimal invasiveness.

The Asia Pacific pharmaceutical industry may witness the introduction of new pharmaceuticals designed to treat androgenetic alopecia. The Asia Pacific region is experiencing a demographic shift with a rising aging population. It is often contribute with aging, and the growing number of elderly individuals contributes to an increased prevalence of hair loss, driving the demand for pharmaceutical interventions in Asia Pacific. Urbanization and changes in lifestyle patterns in the Asia Pacific region contribute to increased stress and lifestyle-related factors, known as contributors to hair loss in Asia Pacific. There is a heightened awareness of androgenetic alopecia and available pharmaceutical solutions in the Asia Pacific region. Therefore, due to the above-mentioned factors, the market will grow significantly in this region.

Free Valuable Insights: The Global Androgenetic Alopecia Market is Predict to reach $ 4.6 Billion by 2030, at a CAGR of 8.1%

Based on Treatment, the market is segmented into Pharmaceuticals, and Devices. Based on Gender, the market is segmented into Male, and Female. Based on Sales Channel, the market is segmented into Prescriptions, and OTC. Based on End-use, the market is segmented into Dermatology Clinics, and Homecare Settings. Based on countries, the market is segmented into China, Japan, India, South Korea, Australia, Malaysia, and Rest of Asia Pacific.

List of Key Companies Profiled

• Cipla Limited
• Merck & Co., Inc.
• GlaxoSmithKline PLC (GSK)
• Sun Pharmaceuticals Industries Ltd.
• Dr.Reddy’s Laboratories Ltd.
• Aurobindo Pharma Limited
• Pfizer, Inc.
• Lutronic Co., Ltd.
• Viatris Inc.
• Eli Lilly and Company

Asia Pacific Androgenetic Alopecia Market Report Segmentation

By Treatment

• Pharmaceuticals
• Devices

By Gender

• Male
• Female

By Sales Channel

• Prescriptions
• OTC

By End-use

• Dermatology Clinics
• Homecare Settings

By Country

• China
• Japan
• India
• South Korea
• Australia
• Malaysia
• Rest of Asia Pacific

Chapter 1. Market Scope & Methodology
1.1 Market Definition
1.2 Objectives
1.3 Market Scope
1.4 Segmentation
1.4.1 Asia Pacific Androgenetic Alopecia Market, by Treatment
1.4.2 Asia Pacific Androgenetic Alopecia Market, by Gender
1.4.3 Asia Pacific Androgenetic Alopecia Market, by Sales Channel
1.4.4 Asia Pacific Androgenetic Alopecia Market, by End-use
1.4.5 Asia Pacific Androgenetic Alopecia Market, by Country
1.5 Methodology for the research

Chapter 2. Market at a Glance
2.1 Key Highlights

Chapter 3. Market Overview
3.1 Introduction
3.1.1 Overview
3.1.1.1 Market Composition and Scenario
3.2 Key Factors Impacting the Market
3.2.1 Market Drivers
3.2.2 Market Restraints
3.2.3 Market Opportunities
3.2.4 Market Challenges
3.3 Porter Five Forces Analysis

Chapter 4. Asia Pacific Androgenetic Alopecia Market, By Treatment
4.1 Asia Pacific Pharmaceuticals Market, By Country
4.2 Asia Pacific Devices Market, By Country

Chapter 5. Asia Pacific Androgenetic Alopecia Market, By Gender
5.1 Asia Pacific Male Market, By Country
5.2 Asia Pacific Female Market, By Country

Chapter 6. Asia Pacific Androgenetic Alopecia Market, By Sales Channel
6.1 Asia Pacific Prescriptions Market, By Country
6.2 Asia Pacific OTC Market, By Country

Chapter 7. Asia Pacific Androgenetic Alopecia Market, By End-use
7.1 Asia Pacific Dermatology Clinics Market, By Country
7.2 Asia Pacific Homecare Settings Market, By Country

Chapter 8. Asia Pacific Androgenetic Alopecia Market, By Country
8.1 China Androgenetic Alopecia Market
8.1.1 China Androgenetic Alopecia Market, By Treatment
8.1.2 China Androgenetic Alopecia Market, By Gender
8.1.3 China Androgenetic Alopecia Market, By Sales Channel
8.1.4 China Androgenetic Alopecia Market, By End-use
8.2 Japan Androgenetic Alopecia Market
8.2.1 Japan Androgenetic Alopecia Market, By Treatment
8.2.2 Japan Androgenetic Alopecia Market, By Gender
8.2.3 Japan Androgenetic Alopecia Market, By Sales Channel
8.2.4 Japan Androgenetic Alopecia Market, By End-use
8.3 India Androgenetic Alopecia Market
8.3.1 India Androgenetic Alopecia Market, By Treatment
8.3.2 India Androgenetic Alopecia Market, By Gender
8.3.3 India Androgenetic Alopecia Market, By Sales Channel
8.3.4 India Androgenetic Alopecia Market, By End-use
8.4 South Korea Androgenetic Alopecia Market
8.4.1 South Korea Androgenetic Alopecia Market, By Treatment
8.4.2 South Korea Androgenetic Alopecia Market, By Gender
8.4.3 South Korea Androgenetic Alopecia Market, By Sales Channel
8.4.4 South Korea Androgenetic Alopecia Market, By End-use
8.5 Australia Androgenetic Alopecia Market
8.5.1 Australia Androgenetic Alopecia Market, By Treatment
8.5.2 Australia Androgenetic Alopecia Market, By Gender
8.5.3 Australia Androgenetic Alopecia Market, By Sales Channel
8.5.4 Australia Androgenetic Alopecia Market, By End-use
8.6 Malaysia Androgenetic Alopecia Market
8.6.1 Malaysia Androgenetic Alopecia Market, By Treatment
8.6.2 Malaysia Androgenetic Alopecia Market, By Gender
8.6.3 Malaysia Androgenetic Alopecia Market, By Sales Channel
8.6.4 Malaysia Androgenetic Alopecia Market, By End-use
8.7 Rest of Asia Pacific Androgenetic Alopecia Market
8.7.1 Rest of Asia Pacific Androgenetic Alopecia Market, By Treatment
8.7.2 Rest of Asia Pacific Androgenetic Alopecia Market, By Gender
8.7.3 Rest of Asia Pacific Androgenetic Alopecia Market, By Sales Channel
8.7.4 Rest of Asia Pacific Androgenetic Alopecia Market, By End-use

Chapter 9. Company Profiles
9.1 Cipla Limited
9.1.1 Company Overview
9.1.2 Financial Analysis
9.1.3 Segmental and Regional Analysis
9.1.4 Research & Development Expense
9.1.5 SWOT Analysis
9.2 Merck & Co., Inc.
9.2.1 Company Overview
9.2.2 Financial Analysis
9.2.3 Segmental and Regional Analysis
9.2.4 Research & Development Expenses
9.2.5 SWOT Analysis
9.3 GlaxoSmithKline PLC (GSK)
9.3.1 Company Overview
9.3.2 Financial Analysis
9.3.3 Regional Analysis
9.3.4 Research & Development Expense
9.3.5 SWOT Analysis
9.4 Sun Pharmaceuticals Industries Ltd.
9.4.1 Company Overview
9.4.2 Financial Analysis
9.4.3 Regional Analysis
9.4.4 Research & Development Expenses
9.4.5 SWOT Analysis
9.5 Dr. Reddy’s Laboratories Ltd.
9.5.1 Company Overview
9.5.2 Financial Analysis
9.5.3 Segmental and Regional Analysis
9.5.4 Research & Development Expense
9.5.5 Recent strategies and developments:
9.5.5.1 Product Launches and Product Expansions:
9.5.6 SWOT Analysis
9.6 Aurobindo Pharma Limited
9.6.1 Company Overview
9.6.2 Financial Analysis
9.6.3 Regional Analysis
9.6.4 Research & Development Expense
9.6.5 SWOT Analysis
9.7 Pfizer, Inc.
9.7.1 Company Overview
9.7.2 Financial Analysis
9.7.3 Regional & Segmental Analysis
9.7.4 Research & Development Expense
9.7.5 Recent strategies and developments:
9.7.5.1 Trails and Approvals:
9.7.6 SWOT Analysis
9.8 Lutronic Co., Ltd.
9.8.1 Company Overview
9.8.2 Financial Analysis
9.8.3 Regional Analysis
9.8.4 Research & Development Expenses
9.8.5 SWOT Analysis
9.9 Viatris, Inc.
9.9.1 Company Overview
9.9.2 Financial Analysis
9.9.3 Segmental Analysis
9.9.4 Research & Development Expense
9.9.5 SWOT Analysis
9.10. Eli Lilly And Company
9.10.1 Company Overview
9.10.2 Financial Analysis
9.10.3 Regional Analysis
9.10.4 Research & Development Expenses
9.10.5 SWOT Analysis

TABLE 1 Asia Pacific Androgenetic Alopecia Market, 2019 - 2022, USD Million
TABLE 2 Asia Pacific Androgenetic Alopecia Market, 2023 - 2030, USD Million
TABLE 3 Asia Pacific Androgenetic Alopecia Market, By Treatment, 2019 - 2022, USD Million
TABLE 4 Asia Pacific Androgenetic Alopecia Market, By Treatment, 2023 - 2030, USD Million
TABLE 5 Asia Pacific Pharmaceuticals Market, By Country, 2019 - 2022, USD Million
TABLE 6 Asia Pacific Pharmaceuticals Market, By Country, 2023 - 2030, USD Million
TABLE 7 Asia Pacific Devices Market, By Country, 2019 - 2022, USD Million
TABLE 8 Asia Pacific Devices Market, By Country, 2023 - 2030, USD Million
TABLE 9 Asia Pacific Androgenetic Alopecia Market, By Gender, 2019 - 2022, USD Million
TABLE 10 Asia Pacific Androgenetic Alopecia Market, By Gender, 2023 - 2030, USD Million
TABLE 11 Asia Pacific Male Market, By Country, 2019 - 2022, USD Million
TABLE 12 Asia Pacific Male Market, By Country, 2023 - 2030, USD Million
TABLE 13 Asia Pacific Female Market, By Country, 2019 - 2022, USD Million
TABLE 14 Asia Pacific Female Market, By Country, 2023 - 2030, USD Million
TABLE 15 Asia Pacific Androgenetic Alopecia Market, By Sales Channel, 2019 - 2022, USD Million
TABLE 16 Asia Pacific Androgenetic Alopecia Market, By Sales Channel, 2023 - 2030, USD Million
TABLE 17 Asia Pacific Prescriptions Market, By Country, 2019 - 2022, USD Million
TABLE 18 Asia Pacific Prescriptions Market, By Country, 2023 - 2030, USD Million
TABLE 19 Asia Pacific OTC Market, By Country, 2019 - 2022, USD Million
TABLE 20 Asia Pacific OTC Market, By Country, 2023 - 2030, USD Million
TABLE 21 Asia Pacific Androgenetic Alopecia Market, By End-use, 2019 - 2022, USD Million
TABLE 22 Asia Pacific Androgenetic Alopecia Market, By End-use, 2023 - 2030, USD Million
TABLE 23 Asia Pacific Dermatology Clinics Market, By Country, 2019 - 2022, USD Million
TABLE 24 Asia Pacific Dermatology Clinics Market, By Country, 2023 - 2030, USD Million
TABLE 25 Asia Pacific Homecare Settings Market, By Country, 2019 - 2022, USD Million
TABLE 26 Asia Pacific Homecare Settings Market, By Country, 2023 - 2030, USD Million
TABLE 27 Asia Pacific Androgenetic Alopecia Market, By Country, 2019 - 2022, USD Million
TABLE 28 Asia Pacific Androgenetic Alopecia Market, By Country, 2023 - 2030, USD Million
TABLE 29 China Androgenetic Alopecia Market, 2019 - 2022, USD Million
TABLE 30 China Androgenetic Alopecia Market, 2023 - 2030, USD Million
TABLE 31 China Androgenetic Alopecia Market, By Treatment, 2019 - 2022, USD Million
TABLE 32 China Androgenetic Alopecia Market, By Treatment, 2023 - 2030, USD Million
TABLE 33 China Androgenetic Alopecia Market, By Gender, 2019 - 2022, USD Million
TABLE 34 China Androgenetic Alopecia Market, By Gender, 2023 - 2030, USD Million
TABLE 35 China Androgenetic Alopecia Market, By Sales Channel, 2019 - 2022, USD Million
TABLE 36 China Androgenetic Alopecia Market, By Sales Channel, 2023 - 2030, USD Million
TABLE 37 China Androgenetic Alopecia Market, By End-use, 2019 - 2022, USD Million
TABLE 38 China Androgenetic Alopecia Market, By End-use, 2023 - 2030, USD Million
TABLE 39 Japan Androgenetic Alopecia Market, 2019 - 2022, USD Million
TABLE 40 Japan Androgenetic Alopecia Market, 2023 - 2030, USD Million
TABLE 41 Japan Androgenetic Alopecia Market, By Treatment, 2019 - 2022, USD Million
TABLE 42 Japan Androgenetic Alopecia Market, By Treatment, 2023 - 2030, USD Million
TABLE 43 Japan Androgenetic Alopecia Market, By Gender, 2019 - 2022, USD Million
TABLE 44 Japan Androgenetic Alopecia Market, By Gender, 2023 - 2030, USD Million
TABLE 45 Japan Androgenetic Alopecia Market, By Sales Channel, 2019 - 2022, USD Million
TABLE 46 Japan Androgenetic Alopecia Market, By Sales Channel, 2023 - 2030, USD Million
TABLE 47 Japan Androgenetic Alopecia Market, By End-use, 2019 - 2022, USD Million
TABLE 48 Japan Androgenetic Alopecia Market, By End-use, 2023 - 2030, USD Million
TABLE 49 India Androgenetic Alopecia Market, 2019 - 2022, USD Million
TABLE 50 India Androgenetic Alopecia Market, 2023 - 2030, USD Million
TABLE 51 India Androgenetic Alopecia Market, By Treatment, 2019 - 2022, USD Million
TABLE 52 India Androgenetic Alopecia Market, By Treatment, 2023 - 2030, USD Million
TABLE 53 India Androgenetic Alopecia Market, By Gender, 2019 - 2022, USD Million
TABLE 54 India Androgenetic Alopecia Market, By Gender, 2023 - 2030, USD Million
TABLE 55 India Androgenetic Alopecia Market, By Sales Channel, 2019 - 2022, USD Million
TABLE 56 India Androgenetic Alopecia Market, By Sales Channel, 2023 - 2030, USD Million
TABLE 57 India Androgenetic Alopecia Market, By End-use, 2019 - 2022, USD Million
TABLE 58 India Androgenetic Alopecia Market, By End-use, 2023 - 2030, USD Million
TABLE 59 South Korea Androgenetic Alopecia Market, 2019 - 2022, USD Million
TABLE 60 South Korea Androgenetic Alopecia Market, 2023 - 2030, USD Million
TABLE 61 South Korea Androgenetic Alopecia Market, By Treatment, 2019 - 2022, USD Million
TABLE 62 South Korea Androgenetic Alopecia Market, By Treatment, 2023 - 2030, USD Million
TABLE 63 South Korea Androgenetic Alopecia Market, By Gender, 2019 - 2022, USD Million
TABLE 64 South Korea Androgenetic Alopecia Market, By Gender, 2023 - 2030, USD Million
TABLE 65 South Korea Androgenetic Alopecia Market, By Sales Channel, 2019 - 2022, USD Million
TABLE 66 South Korea Androgenetic Alopecia Market, By Sales Channel, 2023 - 2030, USD Million
TABLE 67 South Korea Androgenetic Alopecia Market, By End-use, 2019 - 2022, USD Million
TABLE 68 South Korea Androgenetic Alopecia Market, By End-use, 2023 - 2030, USD Million
TABLE 69 Australia Androgenetic Alopecia Market, 2019 - 2022, USD Million
TABLE 70 Australia Androgenetic Alopecia Market, 2023 - 2030, USD Million
TABLE 71 Australia Androgenetic Alopecia Market, By Treatment, 2019 - 2022, USD Million
TABLE 72 Australia Androgenetic Alopecia Market, By Treatment, 2023 - 2030, USD Million
TABLE 73 Australia Androgenetic Alopecia Market, By Gender, 2019 - 2022, USD Million
TABLE 74 Australia Androgenetic Alopecia Market, By Gender, 2023 - 2030, USD Million
TABLE 75 Australia Androgenetic Alopecia Market, By Sales Channel, 2019 - 2022, USD Million
TABLE 76 Australia Androgenetic Alopecia Market, By Sales Channel, 2023 - 2030, USD Million
TABLE 77 Australia Androgenetic Alopecia Market, By End-use, 2019 - 2022, USD Million
TABLE 78 Australia Androgenetic Alopecia Market, By End-use, 2023 - 2030, USD Million
TABLE 79 Malaysia Androgenetic Alopecia Market, 2019 - 2022, USD Million
TABLE 80 Malaysia Androgenetic Alopecia Market, 2023 - 2030, USD Million
TABLE 81 Malaysia Androgenetic Alopecia Market, By Treatment, 2019 - 2022, USD Million
TABLE 82 Malaysia Androgenetic Alopecia Market, By Treatment, 2023 - 2030, USD Million
TABLE 83 Malaysia Androgenetic Alopecia Market, By Gender, 2019 - 2022, USD Million
TABLE 84 Malaysia Androgenetic Alopecia Market, By Gender, 2023 - 2030, USD Million
TABLE 85 Malaysia Androgenetic Alopecia Market, By Sales Channel, 2019 - 2022, USD Million
TABLE 86 Malaysia Androgenetic Alopecia Market, By Sales Channel, 2023 - 2030, USD Million
TABLE 87 Malaysia Androgenetic Alopecia Market, By End-use, 2019 - 2022, USD Million
TABLE 88 Malaysia Androgenetic Alopecia Market, By End-use, 2023 - 2030, USD Million
TABLE 89 Rest of Asia Pacific Androgenetic Alopecia Market, 2019 - 2022, USD Million
TABLE 90 Rest of Asia Pacific Androgenetic Alopecia Market, 2023 - 2030, USD Million
TABLE 91 Rest of Asia Pacific Androgenetic Alopecia Market, By Treatment, 2019 - 2022, USD Million
TABLE 92 Rest of Asia Pacific Androgenetic Alopecia Market, By Treatment, 2023 - 2030, USD Million
TABLE 93 Rest of Asia Pacific Androgenetic Alopecia Market, By Gender, 2019 - 2022, USD Million
TABLE 94 Rest of Asia Pacific Androgenetic Alopecia Market, By Gender, 2023 - 2030, USD Million
TABLE 95 Rest of Asia Pacific Androgenetic Alopecia Market, By Sales Channel, 2019 - 2022, USD Million
TABLE 96 Rest of Asia Pacific Androgenetic Alopecia Market, By Sales Channel, 2023 - 2030, USD Million
TABLE 97 Rest of Asia Pacific Androgenetic Alopecia Market, By End-use, 2019 - 2022, USD Million
TABLE 98 Rest of Asia Pacific Androgenetic Alopecia Market, By End-use, 2023 - 2030, USD Million
TABLE 99 Key Information – Cipla Limited
TABLE 100 Key Information - Merck & Co., Inc.
TABLE 101 Key Information – GlaxoSmithKline PLC
TABLE 102 Key Information – Sun Pharmaceuticals Industries Ltd.
TABLE 103 Key Information – Dr. Reddy’s Laboratories Ltd.
TABLE 104 key information – Aurobindo Pharma Limited
TABLE 105 Key Information – Pfizer, Inc.
TABLE 106 Key Information – lUTRONIC cO., lTD.
TABLE 107 key information – Viatris, Inc.
TABLE 108 Key Information – Eli Lilly And Company

List of Figures
FIG 1 Methodology for the research
FIG 2 Asia Pacific Androgenetic Alopecia Market, 2019 - 2030, USD Million
FIG 3 Key Factors Impacting Androgenetic Alopecia Market
FIG 4 Porter’s Five Forces Analysis – Androgenetic Alopecia Market
FIG 5 Asia Pacific Androgenetic Alopecia Market share, By Treatment, 2022
FIG 6 Asia Pacific Androgenetic Alopecia Market share, By Treatment, 2030
FIG 7 Asia Pacific Androgenetic Alopecia Market, By Treatment, 2019 - 2030, USD Million
FIG 8 Asia Pacific Androgenetic Alopecia Market share, By Gender, 2022
FIG 9 Asia Pacific Androgenetic Alopecia Market share, By Gender, 2030
FIG 10 Asia Pacific Androgenetic Alopecia Market, By Gender, 2019 - 2030, USD Million
FIG 11 Asia Pacific Androgenetic Alopecia Market share, By Sales Channel, 2022
FIG 12 Asia Pacific Androgenetic Alopecia Market share, By Sales Channel, 2030
FIG 13 Asia Pacific Androgenetic Alopecia Market, By Sales Channel, 2019 - 2030, USD Million
FIG 14 Asia Pacific Androgenetic Alopecia Market share, By End-use, 2022
FIG 15 Asia Pacific Androgenetic Alopecia Market share, By End-use, 2030
FIG 16 Asia Pacific Androgenetic Alopecia Market, By End-use, 2019 - 2030, USD Million
FIG 17 Asia Pacific Androgenetic Alopecia Market share, By Country, 2022
FIG 18 Asia Pacific Androgenetic Alopecia Market share, By Country, 2030
FIG 19 Asia Pacific Androgenetic Alopecia Market, By Country, 2019 - 2030, USD Million
FIG 20 SWOT Analysis: Cipla Limited
FIG 21 SWOT Analysis: Merck & Co., Inc.
FIG 22 SWOT Analysis: GlaxoSmithKline PLC
FIG 23 SWOT Analysis: Sun Pharmaceuticals Industries Ltd.
FIG 24 SWOT Analysis: Dr. Reddy’s Laboratories Ltd.
FIG 25 SWOT Analysis: Aurobindo Pharma Limited
FIG 26 SWOT Analysis: Pfizer, Inc.
FIG 27 SWOT Analysis: Lutronic Co., Ltd.
FIG 28 SWOT Analysis: Viatris, Inc.
FIG 29 Swot Analysis: Eli Lilly And Company